{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:25:04Z","timestamp":1783416304041,"version":"3.54.6"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.aohep.2026.102218","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:11:50Z","timestamp":1778109110000},"page":"102218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of the HABIT score: a practical and robust tool to predict hepatic steatosis using HbA1c, BMI, and triglycerides in patients with unexplained elevated liver enzymes"],"prefix":"10.1016","volume":"31","author":[{"given":"Eike","family":"Humbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Wilkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semjon","family":"Bugaichuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Horvatits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar W.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9325-8227","authenticated-orcid":false,"given":"Samuel","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Pischke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5777-1031","authenticated-orcid":false,"given":"Thorben","family":"Fr\u00fcndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.aohep.2026.102218_bib0001","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep4.1899","article-title":"Prevalence and risk factors of advanced liver fibrosis in a population-based study in Germany","volume":"6","author":"Huber","year":"2022","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.aohep.2026.102218_bib0002","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1572-0241.2005.00341.x","article-title":"The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002","volume":"101","author":"Ioannou","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.aohep.2026.102218_bib0003","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States","volume":"98","author":"Clark","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.aohep.2026.102218_bib0004","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1440-1746.2006.04615.x","article-title":"Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan","volume":"22","author":"Chen","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"11\u201312","key":"10.1016\/j.aohep.2026.102218_bib0005","article-title":"Prevalence and metabolic determinants of abnormal alanine aminotransferase: a cross-sectional study of Iranian adults, 2018-2022","volume":"37","author":"Asgari","year":"2023","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"10.1016\/j.aohep.2026.102218_bib0006","doi-asserted-by":"crossref","DOI":"10.5812\/ijem-151542","article-title":"The optimal cut-points of alanine aminotransferase for screening metabolic syndrome in Iranian adults","volume":"23","author":"Asgari","year":"2025","journal-title":"Int J Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.aohep.2026.102218_bib0007","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2016.09.017","article-title":"Extensive testing or focused testing of patients with elevated liver enzymes","volume":"66","author":"Tapper","year":"2017","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2026.102218_bib0008","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/flgastro-2017-100909","article-title":"Development and validation of diagnostic triage criteria for liver disease from a minimum data set enabling the \u201cIntelligent LFT\u201d pathway for the automated assessment of deranged liver enzymes","volume":"9","author":"Miller","year":"2018","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.aohep.2026.102218_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/256426","article-title":"Mild hypertransaminasemia in primary care","volume":"2013","author":"Al-Busafi","year":"2013","journal-title":"ISRN Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2026.102218_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101926","article-title":"Non-alcoholic fatty liver disease, in contrast to alcoholic liver disease, is associated with lower socio-economic status: results from a German referral center","volume":"30","author":"Bugaichuk","year":"2025","journal-title":"Ann Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2026.102218_bib0011","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-2008-1027157","article-title":"Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients","volume":"46","author":"Lobstein","year":"2008","journal-title":"Z Gastroenterol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102218_bib0012","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2211349","article-title":"Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey","volume":"55","author":"Nadolsky","year":"2023","journal-title":"Ann Med"},{"issue":"8","key":"10.1016\/j.aohep.2026.102218_bib0013","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.aohep.2026.102218_bib0014","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"issue":"Suppl","key":"10.1016\/j.aohep.2026.102218_bib0015","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2026.102218_bib0016","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2026.102218_bib0017","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102218_bib0018","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MEG.0000000000000731","article-title":"Multiple biopsy passes and the risk of complications of percutaneous liver biopsy","volume":"29","author":"Chi","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2026.102218_bib0019","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.aohep.2026.102218_bib0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2010.01.008","article-title":"Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations","volume":"52","author":"Lee","year":"2010","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102218_bib0021","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1148\/radiol.10091790","article-title":"Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy","volume":"256","author":"van Werven","year":"2010","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.aohep.2026.102218_bib0022","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.dld.2006.03.021","article-title":"The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis","volume":"38","author":"Palmentieri","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.aohep.2026.102218_bib0023","article-title":"Quantitative ultrasound and ultrasound-based elastography for chronic liver disease: practical guidance, from the AJRspecial series on quantitative imaging","volume":"223","author":"Zhang","year":"2024","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.aohep.2026.102218_bib0024","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1148\/radiol.2523082084","article-title":"Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy\u2013a rapid and accurate technique","volume":"252","author":"Pineda","year":"2009","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.aohep.2026.102218_bib0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1148\/radiol.13121360","article-title":"Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy","volume":"267","author":"Idilman","year":"2013","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.aohep.2026.102218_bib0026","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1148\/radiol.14130863","article-title":"Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy","volume":"271","author":"Hwang","year":"2014","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.aohep.2026.102218_bib0027","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.aohep.2026.102218_bib0028","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.diabet.2016.11.006","article-title":"An extended fatty liver index to predict non-alcoholic fatty liver disease","volume":"43","author":"Kantartzis","year":"2017","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.aohep.2026.102218_bib0029","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.aohep.2026.102218_bib0030","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.aohep.2026.102218_bib0031","article-title":"Comparison of non-invasive liver fat scoring systems as markers of metabolic dysfunction-associated liver disease","volume":"16","author":"Thomson","year":"2024","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.aohep.2026.102218_bib0032","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1478-3231.2012.02767.x","article-title":"Complications and risk factors in 2731 diagnostic mini-laparoscopies in patients with liver disease","volume":"32","author":"Frenzel","year":"2012","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.aohep.2026.102218_bib0033","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2026.102218_bib0034","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MCG.0b013e3181dd1348","article-title":"Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease","volume":"45","author":"Juluri","year":"2011","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.aohep.2026.102218_bib0035","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"NASH clinical research network (CRN). Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.aohep.2026.102218_bib0036","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00108-021-00986-2","article-title":"Europ\u00e4isches referenznetzwerk f\u00fcr seltene lebererkrankungen (ERN RARE-LIVER)","volume":"62","author":"Schulz","year":"2021","journal-title":"Internist"},{"issue":"7","key":"10.1016\/j.aohep.2026.102218_bib0037","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.aohep.2026.102218_bib0038","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2011.03.020","article-title":"Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort","volume":"56","author":"Armstrong","year":"2012","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.aohep.2026.102218_bib0039","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/j.1572-0241.1999.01451.x","article-title":"Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients","volume":"94","author":"Daniel","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.aohep.2026.102218_bib0040","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.20689","article-title":"Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town","volume":"41","author":"Pendino","year":"2005","journal-title":"Hepatology"},{"issue":"10464","key":"10.1016\/j.aohep.2026.102218_bib0041","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"issue":"10308","key":"10.1016\/j.aohep.2026.102218_bib0042","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.aohep.2026.102218_bib0043","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig Liver Dis"},{"issue":"16","key":"10.1016\/j.aohep.2026.102218_bib0044","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.aohep.2026.102218_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.706978","article-title":"Obesity: epidemiology, pathophysiology, and therapeutics","volume":"12","author":"Lin","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.aohep.2026.102218_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155666","article-title":"Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: results from a large multi-center study","volume":"147","author":"Kouvari","year":"2023","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.aohep.2026.102218_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12070664","article-title":"Comparison of the diagnostic performance of steatosis indices for discrimination of CT-diagnosed metabolic dysfunction-associated fatty liver disease","volume":"12","author":"Han","year":"2022","journal-title":"Metabolites"},{"issue":"10","key":"10.1016\/j.aohep.2026.102218_bib0048","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/hepr.13935","article-title":"Validation of fatty liver index as a predictor of hepatic steatosis in Asian populations: impact of alcohol consumption and sex","volume":"53","author":"Nomura","year":"2023","journal-title":"Hepatol Res"},{"issue":"9","key":"10.1016\/j.aohep.2026.102218_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092851","article-title":"Comparative assessment and external validation of hepatic steatosis formulae in a community-based setting","volume":"9","author":"Jung","year":"2020","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.aohep.2026.102218_bib0050","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268126000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268126000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:52:22Z","timestamp":1783414342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268126000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1665268126000396"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102218","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of the HABIT score: a practical and robust tool to predict hepatic steatosis using HbA1c, BMI, and triglycerides in patients with unexplained elevated liver enzymes","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102218"}}